243 related articles for article (PubMed ID: 18710402)
21. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice.
Matsumoto T; Sasaki N; Yamashita T; Emoto T; Kasahara K; Mizoguchi T; Hayashi T; Yodoi K; Kitano N; Saito T; Yamaguchi T; Hirata K
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1141-51. PubMed ID: 27055906
[TBL] [Abstract][Full Text] [Related]
22. By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1.
Kleinpeter P; Remy-Ziller C; Winter E; Gantzer M; Nourtier V; Kempf J; Hortelano J; Schmitt D; Schultz H; Geist M; Brua C; Hoffmann C; Schlesinger Y; Villeval D; Thioudellet C; Erbs P; Foloppe J; Silvestre N; Fend L; Quemeneur E; Marchand JB
J Virol; 2019 Jun; 93(11):. PubMed ID: 30918073
[TBL] [Abstract][Full Text] [Related]
23. CD4(+) T-cell activation is differentially modulated by bacteria-primed dendritic cells, but is generally down-regulated by n-3 polyunsaturated fatty acids.
Brix S; Lund P; Kjaer TM; Straarup EM; Hellgren LI; Frøkiaer H
Immunology; 2010 Mar; 129(3):338-50. PubMed ID: 19909377
[TBL] [Abstract][Full Text] [Related]
24. Efficiency of T-cell costimulation by CD80 and CD86 cross-linking correlates with calcium entry.
Thiel M; Wolfs MJ; Bauer S; Wenning AS; Burckhart T; Schwarz EC; Scott AM; Renner C; Hoth M
Immunology; 2010 Jan; 129(1):28-40. PubMed ID: 19824921
[TBL] [Abstract][Full Text] [Related]
25. Effect of CD80 and CD86 on T cell cytokine production.
Petro TM; Chen SS; Panther RB
Immunol Invest; 1995 Nov; 24(6):965-76. PubMed ID: 8575841
[TBL] [Abstract][Full Text] [Related]
26. Differential requirement for CD28/CTLA-4-CD80/CD86 interactions in drug-induced type 1 and type 2 immune responses to trinitrophenyl-ovalbumin.
Nierkens S; Aalbers M; Bol M; Bleumink R; van Kooten P; Boon L; Pieters R
J Immunol; 2005 Sep; 175(6):3707-14. PubMed ID: 16148116
[TBL] [Abstract][Full Text] [Related]
27. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
28. CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance.
Kurtz J; Raval F; Vallot C; Der J; Sykes M
Blood; 2009 Apr; 113(15):3475-84. PubMed ID: 19179471
[TBL] [Abstract][Full Text] [Related]
29. CTLA-4 (CD152) inhibits the specific lysis mediated by human cytolytic T lymphocytes in a clonally distributed fashion.
Saverino D; Tenca C; Zarcone D; Merlo A; Megiovanni AM; Valle MT; Manca F; Grossi CE; Ciccone E
J Immunol; 1999 Jan; 162(2):651-8. PubMed ID: 9916682
[TBL] [Abstract][Full Text] [Related]
30. T helper-independent activation of human CD8+ cells: the role of CD28 costimulation.
Van Gool SW; Zhang Y; Kasran A; de Boer M; Ceuppens JL
Scand J Immunol; 1996 Jul; 44(1):21-9. PubMed ID: 8693288
[TBL] [Abstract][Full Text] [Related]
31. CD80 (B7-1) and CD86 (B7-2) are functionally equivalent in the initiation and maintenance of CD4+ T-cell proliferation after activation with suboptimal doses of PHA.
Vasilevko V; Ghochikyan A; Holterman MJ; Agadjanyan MG
DNA Cell Biol; 2002 Mar; 21(3):137-49. PubMed ID: 12015893
[TBL] [Abstract][Full Text] [Related]
32. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties.
Vasu C; Wang A; Gorla SR; Kaithamana S; Prabhakar BS; Holterman MJ
Int Immunol; 2003 Feb; 15(2):167-75. PubMed ID: 12578846
[TBL] [Abstract][Full Text] [Related]
33. TCR Signaling and CD28/CTLA-4 Signaling Cooperatively Modulate T Regulatory Cell Homeostasis.
Holt MP; Punkosdy GA; Glass DD; Shevach EM
J Immunol; 2017 Feb; 198(4):1503-1511. PubMed ID: 28053234
[TBL] [Abstract][Full Text] [Related]
34. CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.
Soskic B; Jeffery LE; Kennedy A; Gardner DH; Hou TZ; Halliday N; Williams C; Janman D; Rowshanravan B; Hirschfield GM; Sansom DM
Front Immunol; 2020; 11():577655. PubMed ID: 33488578
[TBL] [Abstract][Full Text] [Related]
35. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
36. Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules.
Linsley PS; Nadler SG; Bajorath J; Peach R; Leung HT; Rogers J; Bradshaw J; Stebbins M; Leytze G; Brady W
J Biol Chem; 1995 Jun; 270(25):15417-24. PubMed ID: 7541042
[TBL] [Abstract][Full Text] [Related]
37. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
[TBL] [Abstract][Full Text] [Related]
38. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
39. Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation.
Kennedy A; Waters E; Rowshanravan B; Hinze C; Williams C; Janman D; Fox TA; Booth C; Pesenacker AM; Halliday N; Soskic B; Kaur S; Qureshi OS; Morris EC; Ikemizu S; Paluch C; Huo J; Davis SJ; Boucrot E; Walker LSK; Sansom DM
Nat Immunol; 2022 Sep; 23(9):1365-1378. PubMed ID: 35999394
[TBL] [Abstract][Full Text] [Related]
40. CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28.
Slavik JM; Hutchcroft JE; Bierer BE
J Biol Chem; 1999 Jan; 274(5):3116-24. PubMed ID: 9915850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
